Media Highlights and Announcements
October 25, 2021
Artrya MD John Barrington on next month’s listing and commercialising AI health tech
Artrya’s co-founder and Managing Director, John Barrington AM, recently took part in a Q&A with Stockhead.
Artrya has lodged a prospectus with ASIC with a view to list on the Australian Stock Exchange.
September 23, 2021
The Technologies Making Moves in Medical Imaging AI
We’re proud to be acknowledged in Signify Research’s Product Developments & Technology Trends report.
Business NewsJune 21, 2021
Researchers Eye Health Benefit From AI
Several exciting AI innovations are emerging from WA, and the world is watching.
University of Western AustraliaMay 31, 2021
Artificial Intelligence To Predict Heart Disease
AI to predict heart disease.
Australian Financial ReviewMay 25, 2021
AI-powered imaging software has raised $15 million from institutional investors
Artrya raises $15m for AI software to transform cardiac imaging.
March 31, 2021
Artrya Marches To Its Own Beat – MTPConnect Podcast
MTPConnect talks to Artrya. In this week’s episode, we chat with WA-based digital health company Artrya’s Co-Founders.
December 10, 2020
Artrya Is On The Pulse
Artificial Intelligence (AI) is changing the face of healthcare, and Artrya wants to redefine how the risk of heart disease is detected in patients.
AusbizNovember 26, 2020
AI Medtech Artrya lists on stock exchange with market cap of $105M
Artificial intelligence medical technology company Artrya (AYA) listed on the ASX today following the completion of its $40 million raise.
ArtryaJuly 10, 2020
Artrya Secures Funding For World-First Healthcare Technology
Emerging WA medtech star awarded Federal Government grant for commercialisation of artificial-intelligence (AI) technology that fights heart disease.